中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/29053
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 29490/55136 (53%)
造访人次 : 1995964      在线人数 : 500
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于CMUR管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29053


    题名: Novel clonal der(8)t(8;14)(p11;q11),del(9)(q13q22) and t(14;22) (q13;q13) in a patient with fulminant adult T-cell leukemia/lymphoma
    作者: Yeh, SP;Yu, MT;Chow, KC;Lai, LY;Chiu, CF
    贡献者: 附設醫院內科部血液腫瘤科;China Med Coll Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Canc Res Ctr, Stem Cell Res Lab, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Cytogenet Lab, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Canc Res Ctr, Taichung 404, Taiwan
    日期: 2002
    上传时间: 2010-09-24 14:20:00 (UTC+8)
    出版者: ELSEVIER SCIENCE INC
    摘要: Tissue polypeptide specific antigen (TPS) is a new tumor marker that indicates tumor proliferative rate rather than tumor burden. The purpose of this study was to assess the clinical value of TPS in patients with renal cell carcinoma (RCC). Serum levels of TPS were measured in 30 patients with locoregional and in 20 patients with advanced disease before and after therapy. The results showed that: (1) the detection sensitivity of TPS for RCC is 60.0%; (2) the detection sensitivity of TPS in advanced RCC (100.0%) was significantly higher than in locoregional RCC (33.3%); (3) the 10 locoregional RCC patients without recurrence had normal serum TPS levels during a follow-up period of 1 year; and (4) the 8 advanced RCC patients with good response during therapy had normal serum TPS levels, while 12 patients with poor disease had significantly elevated serum TPS levels during a follow-up period of 1 year. Our results suggest that TPS may have a potential clinical role as a valuable tumor marker for RCC, especially in advanced diseases and follow-up therapy response.
    關聯: CANCER GENETICS AND CYTOGENETICS 139(1):34-37
    显示于类别:[台中附設醫院] 期刊論文

    文件中的档案:

    没有与此文件相关的档案.



    在CMUR中所有的数据项都受到原著作权保护.

    TAIR相关文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈